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Background
Recent data have demonstrated a lower mortality in
acute ST-elevation myocardial infarction (STEMI)
patients with previous treatment with statins, especially
in patients with high risk profiles. Moreover, a signifi-
cant reduction in enzymatic infarct size in non-STEMI
patients could be observed. However, systematic data of
the impact of chronic statin pre-treatment on myocar-
dial damage and reperfusion injury assessed with the
gold standard cardiac magnetic resonance imaging
(CMR) are lacking.
The aim of our prospective study was therefore to
assess the effects of a chronic statin pre-treatment on
myocardial damage as assessed by CMR in patients with
acute reperfused STEMI.
Methods
We enrolled 220 consecutive patients with acute STEMI
undergoing primary PCI within 12 hours of symptom
onset in our study. CMR studies were performed 2-4
days after the index eventinfarction (median 3 days,
interquartile range 2, 4 days) using a standard infarction
protocol.
Results
Of 220 patients, 35 (15.9 %) had chronic statin pre-
treatment. There was no difference in pain-to-balloon
time between the two groups (statin vs. no statins: 300.2
±178.2 vs. 288.7±179.8 min, p=0.73), but the statin
group showed a trend towards a higher TIMI risk-score
(4.5±2.0 vs. 3.7±2.3, p=0.054) and higher age (68.7±11.0
vs. 64.9±12.6 years, p=0.09). In cMRI no differences in
the area at risk (35.8±12.9 vs. 35.6±10.9 %LV, p=0.96)
and left ventricular ejection fraction (48.4±11.4 vs. 50.5
±12.0 %, p=0.35) could be observed. Infarct size showed
no statistical significant difference (18.0±11.5 vs. 15.3
±12.0 %LV, p=0.23) but statin pre-treatment resulted in
a significant higher myocardial salvage index as com-
pared to patients without statin pre-treatment (59.8
±27.4 vs. 49.1±27.0, p=0.04).
Conclusions
Statin pretreatment in patients with STEMI is associated
with a higher myocardial salvage index and may explain
the recently observed improved short time survival. Lar-
ger studies are needed to conclusively ascertain our
results.
Funding
None.
Published: 1 February 2012
doi:10.1186/1532-429X-14-S1-O67
Cite this article as: Fuernau et al.: Impact of chronic statin-pretreatment
on myocardial damage as assessed by Cardiac Magnetic Resonance
findings in patients with acute ST-elevation myocardial infarction.
Journal of Cardiovascular Magnetic Resonance 2012 14(Suppl 1):O67.
Clinic for Internal Medicine/Cardiology, University of Leipzig - Heartcenter,
Leipzig, Germany
Fuernau et al. Journal of Cardiovascular Magnetic Resonance 2012, 14(Suppl 1):O67
http://www.jcmr-online.com/content/14/S1/O67
© 2012 Fuernau et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.